Contact Us

Resources

The benefits of CDMOs with customer-centric approaches and cohesive teams

The benefits of CDMOs with customer-centric approaches and cohesive teams

In the highly competitive and rapidly evolving biopharma industry, choosing the right contract development and manufacturing organization (CDMO) is a critical decision that can significantly impact the success of a pharmaceutical development journey. When exploring potential CDMO partners, two key factors to consider are whether the company has a customer-centric approach, and if the team itself...

read more
Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Taiwan, 31st July 2023: Bora Pharmaceuticals, a leading contract development and manufacturing organization (CDMO), is pleased to announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of Taiwan Operations Tom Chang, the facility will provide Bora’s customers with access to an extensive range...

read more
Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

Bora has been awarded "Outstanding Company of the Year" by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place in Taipei, Taiwan July 24-26, 2023. Bora was chosen from a short list of several candidates for its demonstrated leadership in the Taiwan Biopharma industry. Bobby Sheng said; "Our team's focused dedication to excellence in quality and customer...

read more
Bora Pharmaceuticals Featured in Contract Pharma – What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?

Bora Pharmaceuticals Featured in Contract Pharma – What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?

,

Read Contract Pharma - "What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?" Published on June 22, 2023 Bobby Sheng sheds some light on the three main trends impacting CDMOs in 2023 - and potentially for many years ahead. One such trend is an increased demand for the production of novel biologics. The rising need for biologics means more pressure on the industry to bring these...

read more
Skip to content